MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $4,824 | $3,475 | $3,585 | $3,243 |
| % Growth | 38.8% | -3.1% | 10.6% | – |
| Cost of Goods Sold | $3,154 | $2,899 | $2,695 | $2,564 |
| Gross Profit | $1,670 | $577 | $890 | $679 |
| % Margin | 34.6% | 16.6% | 24.8% | 20.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $436 | $0 | $809 | $0 |
| SG&A Expenses | $1,028 | $1,213 | $971 | $989 |
| Sales & Mktg Exp. | $78 | $0 | $162 | $0 |
| Other Operating Expenses | $23 | $0 | $0 | $0 |
| Operating Expenses | $1,051 | $1,213 | $971 | $1,013 |
| Operating Income | $619 | -$637 | -$81 | -$310 |
| % Margin | 12.8% | -18.3% | -2.3% | -9.6% |
| Other Income/Exp. Net | $14 | $52 | $453 | -$41 |
| Pre-Tax Income | $632 | -$585 | $372 | -$351 |
| Tax Expense | -$94 | $4 | -$98 | $4 |
| Net Income | $731 | -$582 | $470 | -$355 |
| % Margin | 15.2% | -16.8% | 13.1% | -10.9% |
| EPS | 68.9 | -118.56 | 86.32 | -72.72 |
| % Growth | 158.1% | -237.3% | 218.7% | – |
| EPS Diluted | 118.73 | -118.56 | 86.32 | -72.72 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 6 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | -$16 | $17 |
| Interest Expense | $0 | $21 | $0 | $0 |
| Depreciation & Amortization | $94 | $196 | $152 | $101 |
| EBITDA | $828 | -$441 | $70 | -$209 |
| % Margin | 17.2% | -12.7% | 2% | -6.5% |